967452091	967452091	CD	B-NP	O
|	|	NN	I-NP	O
NMC	NMC	NN	I-NP	O
|	|	NN	I-NP	O
25014713	25014713	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0430432	0430432	CD	B-NP	O
|	|	CC	I-NP	O
3/2/2007	3/2/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
GI	GI	NNP	I-NP	I-protein
Bleeding	Bleeding	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/27/2007	1/27/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/10/2007	1/10/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
STEIN	STEIN	NN	I-NP	B-protein
,	,	,	O	O
STERLING	STERLING	VBG	B-VP	O
519-38-01-2	519-38-01-2	CD	B-NP	O
So	So	NNP	I-NP	O
Lo	Lo	NNP	I-NP	O
Ster	Ster	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/2/07	1/2/07	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
CONTINGENT	CONTINGENT	JJ	B-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CABECEIRA	CABECEIRA	NNP	B-NP	O
,	,	,	O	O
OSCAR	OSCAR	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

DULOXETINE	DULOXETINE	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

PANTOPRAZOLE	PANTOPRAZOLE	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
PROTONIX	PROTONIX	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
CYMBALTA	CYMBALTA	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
call	call	VBP	B-VP	O
the	the	DT	B-NP	O
GI	GI	NN	I-NP	B-protein
clinic	clinic	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
753-502-9848	753-502-9848	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Please	Please	NNP	B-NP	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
GI	GI	NNP	B-NP	O
Bleeding	Bleeding	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GI	GI	NNP	I-NP	O
Bleeding	Bleeding	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
s/p	s/p	NN	I-NP	O
gastric	gastric	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Roux	Roux	NNP	I-NP	O
en	en	NNP	I-NP	O
Y	Y	NNP	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
Depression	Depression	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

EGD	EGD	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
11/27/07	11/27/07	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Nicks	Nicks	NNP	I-NP	O
,	,	,	O	O
GI	GI	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Colonoscopy	Colonoscopy	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/3/07	4/3/07	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Shanks	Shanks	NNP	I-NP	O
,	,	,	O	O
GI	GI	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Abd	Abd	NNP	I-NP	O
CT	CT	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Melena	Melena	NNP	B-NP	O
,	,	,	O	O
Lightheaded	Lightheaded	NNP	B-NP	O
HPI	HPI	NNP	I-NP	O
:	:	:	O	O
46F	46F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
h/o	h/o	NN	I-NP	B-protein
obesity	obesity	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
laparoscopic	laparoscopic	JJ	I-NP	I-protein
Roux-en-Y	Roux-en-Y	NN	I-NP	I-protein
gastric	gastric	JJ	I-NP	I-protein
bypass	bypass	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
15	15	CD	I-NP	I-protein
mos	mo	NNS	I-NP	I-protein
prior	prior	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
p/w	p/w	NN	I-NP	O
melena	melena	NN	I-NP	O
and	and	CC	I-NP	O
LH	LH	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
feldene	feldene	NN	B-NP	B-protein
approx	approx	NN	I-NP	I-protein
6	6	CD	B-NP	I-protein
wks	wk	NNS	I-NP	I-protein
prior	prior	JJ	B-NP	I-protein
2/2	2/2	CD	I-NP	I-protein
joint	joint	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Subsequently	Subsequently	RB	B-NP	O
w	w	JJ	I-NP	O
/	/	SYM	I-NP	O
epigastric	epigastric	JJ	I-NP	B-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
after	after	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
protonix	protonix	NN	B-NP	O
.	.	.	O	O

1d	1d	CD	B-NP	O
PTA	PTA	NN	I-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
episode	episode	NN	B-NP	O
of	of	IN	B-PP	O
melena	melena	NN	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
LH	LH	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
AM	AM	NN	B-NP	O
of	of	IN	B-PP	O
adm	adm	NN	B-NP	O
had	have	VBD	B-VP	O
2nd	2nd	JJ	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
melena	melena	NN	B-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
LH	LH	NN	B-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

Found	Found	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
SBP	SBP	NN	B-NP	B-protein
in	in	IN	B-PP	O
80	80	CD	B-NP	O
's	's	POS	B-NP	O
at	at	IN	B-PP	O
work	work	NN	B-NP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
CCVMC	CCVMC	NN	B-NP	O
ED	ED	NN	I-NP	O
***************************************************	***************************************************	SYM	B-NP	O
ED	ED	NN	I-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
HR	HR	NN	B-NP	B-DNA
74	74	CD	I-NP	I-DNA
,	,	,	O	O
BP	BP	NN	B-NP	O
120/60	120/60	CD	I-NP	O
supine	supine	NN	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
HR	HR	NN	B-NP	B-protein
99	99	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	O
129/68	129/68	CD	I-NP	O
standing	standing	NN	I-NP	O
,	,	,	O	O
guiaic	guiaic	JJ	B-NP	O
pos	po	NNS	I-NP	O
,	,	,	O	O
HCT	HCT	NN	B-NP	B-DNA
24	24	CD	I-NP	I-DNA
,	,	,	O	O
transfused	transfuse	VBN	B-NP	O
2u	2u	NN	I-NP	O
RBC	RBC	NNP	B-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
GGT	GGT	NNP	I-NP	O
,	,	,	O	O
NPO	NPO	NNP	B-NP	B-protein
.	.	.	O	O

CT	CT	NN	B-NP	B-protein
abd	abd	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
s/p	s/p	NN	I-NP	O
roux	roux	NN	I-NP	O
en	en	IN	B-PP	O
y	y	NN	B-NP	O
,	,	,	O	O
o/w	o/w	NN	B-NP	O
nl	nl	NN	I-NP	O
***************************************************	***************************************************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
Morbid	Morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
s/p	s/p	NN	I-NP	O
gastric	gastric	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
fibromyalgia	fibromyalgia	NN	B-NP	O
,	,	,	O	O
Type1	Type1	NN	B-NP	O
VWD	VWD	NN	I-NP	O
,	,	,	O	O
migraines	migraine	NNS	B-NP	O
***************************************************	***************************************************	SYM	O	O
ADMISSION	ADMISSION	NN	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
Feldene	Feldene	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
not	not	RB	B-VP	O
taking	take	VBG	I-VP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
,	,	,	O	O
Cymbalta	Cymbalta	NNP	B-NP	O
ALL	ALL	NNP	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
***************************************************	***************************************************	SYM	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
pale	pale	JJ	B-NP	O
conjunctiva	conjunctiva	NN	I-NP	O
,	,	,	O	O
jvp	jvp	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
rrr	rrr	NN	B-NP	B-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
,	,	,	O	O
heme	heme	NN	B-NP	B-protein
pos	po	NNS	I-NP	I-protein
stool	stool	NN	I-NP	I-protein
***************************************************	***************************************************	SYM	B-NP	I-protein
ADMISSION	ADMISSION	NN	I-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
141	141	CD	B-NP	O
109	109	CD	I-NP	O
23	23	CD	I-NP	O
--	--	:	O	O
+	+	SYM	B-NP	O
--	--	:	O	O
--	--	SYM	O	O
-	-	HYPH	O	O
+	+	SYM	B-NP	O
--	--	:	O	O
<	<	SYM	O	O
159	159	CD	B-NP	O
4.6	4.6	CD	I-NP	O
>	>	SYM	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	B-DNA
<	<	SYM	B-NP	I-DNA
203	203	CD	I-NP	I-DNA
3.7	3.7	CD	I-NP	I-DNA
27	27	CD	I-NP	I-DNA
0.7	0.7	CD	I-NP	I-DNA
24.2	24.2	CD	I-NP	I-DNA
*************************************************	*************************************************	SYM	I-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	SYM	B-NP	O
-	-	HYPH	B-NP	O
Abd	Abd	NN	I-NP	O
CT	CT	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
11/27/07	11/27/07	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
intact	intact	JJ	B-NP	O
anastamosis	anastamosis	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
roux	roux	NN	I-NP	O
en	en	IN	B-PP	O
y	y	NN	B-NP	O
,	,	,	O	O
o/w	o/w	IN	B-PP	O
normal	normal	JJ	B-NP	O
-	-	HYPH	I-NP	O
EGD	EGD	NN	I-NP	B-protein
-LRB-	-LRB-	SYM	O	O
11/27/07	11/27/07	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
nl	nl	NN	B-NP	O
GEJ	GEJ	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
few	few	JJ	I-NP	O
shallow	shallow	JJ	I-NP	O
erosions	erosion	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
e/o	e/o	NN	I-NP	O
significant	significant	JJ	I-NP	O
esophagitis	esophagitis	NN	I-NP	O
or	or	CC	I-NP	O
ulcerations	ulceration	NNS	I-NP	O
.	.	.	O	O

intact	intact	JJ	B-NP	O
anastamosis	anastamosis	NN	I-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
-	-	HYPH	B-NP	O
Colonoscopy	Colonoscopy	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/3/07	4/3/07	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
normal	normal	JJ	B-NP	O
*************************************************	*************************************************	SYM	I-NP	O
CONSULTING	CONSULTING	NN	I-NP	O
SERVICES	SERVICES	NNS	I-NP	O
:	:	:	O	O
GI	GI	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Stielau	Stielau	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Borglum	Borglum	NNP	I-NP	O
*************************************************	*************************************************	NNP	I-NP	O
*************************************************	*************************************************	NNP	I-NP	O
Assessment	Assessment	NNP	I-NP	O
:	:	:	O	O
46F	46F	NN	B-NP	O
s/p	s/p	NN	I-NP	O
gastric	gastric	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
NSAID	NSAID	NN	I-NP	O
use	use	NN	I-NP	O
p/w	p/w	NN	I-NP	O
melena	melena	NN	I-NP	O
,	,	,	O	O
LH	LH	NN	B-NP	O
,	,	,	O	O
rel	rel	NN	B-NP	O
hypotension	hypotension	NN	I-NP	O
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
HCT	HCT	NN	B-NP	B-DNA
24	24	CD	I-NP	I-DNA
-LRB-	-LRB-	:	O	O
baseline	baseline	NN	B-NP	O
36	36	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
bleeding	bleeding	NN	I-NP	O
and	and	CC	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
to	to	TO	B-PP	O
units	unit	NNS	B-NP	O
of	of	IN	B-PP	O
pRBC	pRBC	NN	B-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
for	for	IN	B-PP	O
HCT	HCT	NN	B-NP	O
=	=	SYM	B-VP	O
24	24	CD	B-NP	O
--	--	:	O	O
>	>	SYM	O	O
28	28	CD	O	O
--	--	SYM	O	O
>	>	SYM	O	O
31	31	CD	B-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
28	28	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
nexium	nexium	NN	I-NP	O
iv	iv	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
PPI	PPI	NN	I-NP	O
once	once	RB	O	O
EGD	EGD	NN	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
and	and	CC	O	O
no	no	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleeding	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O
-LRB-	-LRB-	NNP	B-NP	O
as	as	IN	B-PP	O
above	above	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
colonoscopy	colonoscopy	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
fully	fully	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
melena	melena	NN	B-NP	O
occured	occur	VBN	B-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
avoid	avoid	VB	I-VP	O
NSAIDs	NSAID	NNS	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
Protonix	Protonix	NNP	B-NP	O
40mg	40mg	CD	I-NP	O
BID	BID	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
HCT	HCT	NN	I-NP	O
rechecked	rechecke	VBD	B-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
the	the	DT	B-NP	O
GI	GI	NN	I-NP	O
office	office	NN	I-NP	O
for	for	IN	B-PP	O
followup	followup	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
iron	iron	NN	I-NP	B-protein
studies	study	NNS	I-NP	I-protein
-LRB-	-LRB-	CC	O	I-protein
fe	fe	VBP	B-VP	O
20	20	CD	B-NP	O
,	,	,	O	O
TIBC	TIBC	NNP	B-NP	B-cell_line
361	361	CD	I-NP	I-cell_line
,	,	,	O	O
Ferr	Ferr	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
an	an	DT	B-NP	O
informational	informational	JJ	I-NP	O
sheet	sheet	NN	I-NP	O
on	on	IN	B-PP	O
good	good	JJ	B-NP	O
nutritional	nutritional	JJ	I-NP	O
sources	source	NNS	I-NP	O
of	of	IN	B-PP	O
iron	iron	NN	B-NP	O
for	for	IN	B-PP	O
repletion	repletion	NN	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
CONTACT	CONTACT	NN	I-NP	O
:	:	:	O	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
Bleeding	Bleeding	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
endoscopy	endoscopy	NN	I-NP	O
and	and	CC	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
upper	upper	JJ	I-NP	O
endoscopy	endoscopy	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
mild	mild	JJ	B-NP	O
erosions	erosion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
esophagus	esophagus	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
identify	identify	VB	I-VP	O
a	a	DT	B-NP	O
definite	definite	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
As	As	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
including	include	VBG	B-PP	O
Naproxen	Naproxen	NNP	B-NP	O
,	,	,	O	O
Ibuprofen	Ibuprofen	NNP	B-NP	O
,	,	,	O	O
feldene	feldene	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NNP	B-NP	O
Bleeding	Bleeding	NNP	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
use	use	VB	I-VP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
safe	safe	JJ	I-NP	O
alternative	alternative	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
for	for	IN	B-PP	O
you	you	PRP	B-NP	O
.	.	.	O	O

-	-	HYPH	O	O
You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
have	have	VB	I-VP	O
your	your	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
rechecked	rechecke	VBD	B-VP	O
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
November	November	NNP	B-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	DT	O	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
levels	level	NNS	I-NP	O
are	be	VBP	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

-	-	HYPH	O	O
Your	Your	PRP$	B-NP	O
iron	iron	NN	I-NP	O
stores	store	NNS	I-NP	O
are	be	VBP	B-VP	O
low	low	JJ	B-ADJP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
your	your	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
have	have	VBP	B-VP	O
given	give	VBN	I-VP	O
you	you	PRP	B-NP	O
a	a	DT	B-NP	O
handout	handout	NN	I-NP	O
listing	list	VBG	B-VP	O
good	good	JJ	B-NP	O
nutritional	nutritional	JJ	I-NP	O
sources	source	NNS	I-NP	O
of	of	IN	B-PP	O
iron	iron	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	B-protein
seek	seek	VBP	B-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
bleeding	bleeding	NN	I-NP	O
recurs	recur	VBZ	B-VP	O
or	or	CC	O	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
racing	racing	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	O
recheck	recheck	NN	I-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
stability	stability	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	B-protein
recheck	recheck	VB	B-VP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
iron	iron	NN	I-NP	O
studies	study	NNS	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
they	they	PRP	B-NP	O
recover	recover	VBP	B-VP	O
appropriately	appropriately	RB	B-ADVP	O
with	with	IN	B-PP	O
nutritional	nutritional	JJ	B-NP	O
iron	iron	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KESTER	KESTER	NNP	B-NP	O
,	,	,	O	O
DOUGLASS	DOUGLASS	NNP	B-NP	O
C	C	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
JQ416	JQ416	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/2/07	1/2/07	CD	I-NP	O
@	@	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
24	24	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

